[go: up one dir, main page]

WO2003009783A1 - Laminates for treating cornea and process for producing the same - Google Patents

Laminates for treating cornea and process for producing the same Download PDF

Info

Publication number
WO2003009783A1
WO2003009783A1 PCT/JP2002/007491 JP0207491W WO03009783A1 WO 2003009783 A1 WO2003009783 A1 WO 2003009783A1 JP 0207491 W JP0207491 W JP 0207491W WO 03009783 A1 WO03009783 A1 WO 03009783A1
Authority
WO
WIPO (PCT)
Prior art keywords
cornea
laminates
face
contact
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/007491
Other languages
French (fr)
Japanese (ja)
Inventor
Minoru Ueda
Ken-Ichiro Hata
Koji Hirano
Kazuhiro Kito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tissue Engineering Co Ltd
Original Assignee
Japan Tissue Engineering Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tissue Engineering Co Ltd filed Critical Japan Tissue Engineering Co Ltd
Priority to JP2003515179A priority Critical patent/JPWO2003009783A1/en
Priority to KR10-2003-7016445A priority patent/KR20040024859A/en
Publication of WO2003009783A1 publication Critical patent/WO2003009783A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

It is intended to provide laminates for treating cornea which are efficacious in treating cornea and excellent in convenience and thus can facilitate the treatment of cornea. These laminates are composed of a base material having a curved face allowing the loading thereof on the cornea and a cell layer provided directly or indirectly at least on the face of the base material to be in contact with the cornea and/or the face not to be in contact with the cornea. These laminates having a cell layer on the face to be in contact with the cornea are prepared by inoculating oral mucosa epithelial cells into the inside of a collagen shield, culturing the cells for 14 days and thus forming a cell layer consisting of the oral mucosa epithelial cells on the face to be in contact with the cornea.
PCT/JP2002/007491 2001-07-25 2002-07-24 Laminates for treating cornea and process for producing the same Ceased WO2003009783A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2003515179A JPWO2003009783A1 (en) 2001-07-25 2002-07-24 Laminate for corneal treatment and method for producing the same
KR10-2003-7016445A KR20040024859A (en) 2001-07-25 2002-07-24 Laminates for treating cornea and process for producing the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001224699 2001-07-25
JP2001-224699 2001-07-25

Publications (1)

Publication Number Publication Date
WO2003009783A1 true WO2003009783A1 (en) 2003-02-06

Family

ID=19057815

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/007491 Ceased WO2003009783A1 (en) 2001-07-25 2002-07-24 Laminates for treating cornea and process for producing the same

Country Status (3)

Country Link
JP (1) JPWO2003009783A1 (en)
KR (1) KR20040024859A (en)
WO (1) WO2003009783A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006003818A1 (en) * 2004-06-30 2006-01-12 Alblast Co., Ltd. Corneal epithelial sheet and process for producing the same
JPWO2005047496A1 (en) * 2003-11-14 2007-05-31 学校法人慶應義塾 Cell culture method, cell three-dimensional culture method, three-dimensional tissue, artificial organ, and tissue transplantation method
CN100333702C (en) * 2004-04-28 2007-08-29 浙江大学医学院附属邵逸夫医院 Exogenous cornea substrate without cells and its preparation method and use
WO2008105454A1 (en) 2007-02-28 2008-09-04 Senju Pharmaceutical Co., Ltd. Cell capable of expressing lacritin at high level
EP2417933A3 (en) * 2010-08-11 2012-08-22 Body Organ Biomedical Corp. Bio-sheet for eye tissue repair
US10457913B2 (en) 2015-01-13 2019-10-29 Osaka University Corneal epithelioid cells derived from surface ectodermal cells
JP2021518136A (en) * 2018-03-22 2021-08-02 クイーン メアリー ユニバーシティ オブ ロンドン Implant-type cell dressing to treat diseases

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021152083A2 (en) 2020-01-31 2021-08-05 Schott Ag Pane-like article and its use, and household appliance comprising the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192316A (en) * 1988-02-16 1993-03-09 Allergan, Inc. Ocular device
US5374515A (en) * 1992-11-13 1994-12-20 Organogenesis, Inc. In vitro cornea equivalent model
US5827641A (en) * 1992-11-13 1998-10-27 Parenteau; Nancy L. In vitro cornea equivalent model
US5836313A (en) * 1993-02-08 1998-11-17 Massachusetts Institute Of Technology Methods for making composite hydrogels for corneal prostheses

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192316A (en) * 1988-02-16 1993-03-09 Allergan, Inc. Ocular device
US5374515A (en) * 1992-11-13 1994-12-20 Organogenesis, Inc. In vitro cornea equivalent model
US5827641A (en) * 1992-11-13 1998-10-27 Parenteau; Nancy L. In vitro cornea equivalent model
US5836313A (en) * 1993-02-08 1998-11-17 Massachusetts Institute Of Technology Methods for making composite hydrogels for corneal prostheses

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005047496A1 (en) * 2003-11-14 2007-05-31 学校法人慶應義塾 Cell culture method, cell three-dimensional culture method, three-dimensional tissue, artificial organ, and tissue transplantation method
CN100333702C (en) * 2004-04-28 2007-08-29 浙江大学医学院附属邵逸夫医院 Exogenous cornea substrate without cells and its preparation method and use
WO2006003818A1 (en) * 2004-06-30 2006-01-12 Alblast Co., Ltd. Corneal epithelial sheet and process for producing the same
WO2008105454A1 (en) 2007-02-28 2008-09-04 Senju Pharmaceutical Co., Ltd. Cell capable of expressing lacritin at high level
EP2417933A3 (en) * 2010-08-11 2012-08-22 Body Organ Biomedical Corp. Bio-sheet for eye tissue repair
US10457913B2 (en) 2015-01-13 2019-10-29 Osaka University Corneal epithelioid cells derived from surface ectodermal cells
JP2021518136A (en) * 2018-03-22 2021-08-02 クイーン メアリー ユニバーシティ オブ ロンドン Implant-type cell dressing to treat diseases
JP7519298B2 (en) 2018-03-22 2024-07-19 クイーン メアリー ユニバーシティ オブ ロンドン Implantable cell dressings for treating diseases
JP2024129142A (en) * 2018-03-22 2024-09-26 クイーン メアリー ユニバーシティ オブ ロンドン Implantable cell dressings for treating diseases
US12171911B2 (en) 2018-03-22 2024-12-24 Queen Mary University Of London Implantable cell dressing for treatment of disease

Also Published As

Publication number Publication date
JPWO2003009783A1 (en) 2004-11-11
KR20040024859A (en) 2004-03-22

Similar Documents

Publication Publication Date Title
EP1454600A4 (en) Ectocornea-like sheet and method of constructing the same
AU2003249310A1 (en) Soft tissue implants and methods for making same
ATE235230T1 (en) INCORPORATING BIOLOGICALLY ACTIVE MOLECULES IN BIOACTIVE GLASS
CA2026915A1 (en) Stem cell factor
AU4221399A (en) Human cd45+ and/or fibroblast + mesenchymal stem cells
AU3993495A (en) Process for producing transformed cell
ATE253948T1 (en) IN VITRO PROCESS FOR PRODUCING A HOMOLOGOUS HEART VALVE OR VASCULAR PROSTHESIS
NZ506267A (en) Modified ciliary neurotrophic factor, method of making and methods of use thereof
EP0396138A3 (en) Method for growing cellular tissue
AU2003234962A1 (en) A wear part intended for a crusher and a method of manufacturing the same
DE69426692D1 (en) METHOD FOR PRODUCING TAXAN DITERPES AND METHOD FOR UNITING CULTURE CELLS THAT MANUFACTURE TAXAN DITERPES IN HIGH YIELDS
FR15C0055I2 (en) IN VITRO RECONSTRUCTED HUMAN CORNEAL EPITHELIUM SHEETS AND METHOD FOR PRODUCING THEM
WO2003009783A1 (en) Laminates for treating cornea and process for producing the same
CA2147123A1 (en) Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo
EP1536500A4 (en) Electrode for fuel cell, fuel cell including the electrode and process for producing the same
WO2003089581A3 (en) A method to increase the rate of cell growth
AU6505394A (en) Tumoricide t lymphocytes
MXPA05007021A (en) Integral gutta percha technique.
De Hoog et al. A new dematiaceous fungus from human skin
WO2003078607A3 (en) Tissue specific signal-plexes to dedifferentiate and redifferentiate cells
WO2000073420A3 (en) Creation of human tumorigenic cells and uses therefor
EP0945073A3 (en) Process of production of natural flavor or fragrance
WO2002083860A9 (en) Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
HK1048135A1 (en) High level cytokine production with enhanced cell viability
AU1929397A (en) Use of il-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003515179

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 1020037016445

Country of ref document: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase